151 related articles for article (PubMed ID: 36074157)
1. First-in-human evaluation of [
Silins I; Sundin A; Lubberink M; O'Sullivan L; Gurnell M; Aigbirhio F; Brown M; Wall A; Åkerström T; Roslin S; Hellman P; Antoni G
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):398-409. PubMed ID: 36074157
[TBL] [Abstract][Full Text] [Related]
2. Para-chloro-2-[
Silins I; Sundin A; Nordeman P; Jahan M; Estrada S; Monazzam A; Lubberink M; Aigbirhio F; Hellman P; Antoni G
Int J Med Sci; 2021; 18(10):2187-2196. PubMed ID: 33859526
[No Abstract] [Full Text] [Related]
3. 18F-FDG PET/CT image findings of a dog with adrenocortical carcinoma.
Lee D; Yun T; Koo Y; Chae Y; Chang D; Yang MP; Kang BT; Kim H
BMC Vet Res; 2022 Jan; 18(1):15. PubMed ID: 34980137
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
Burton TJ; Mackenzie IS; Balan K; Koo B; Bird N; Soloviev DV; Azizan EA; Aigbirhio F; Gurnell M; Brown MJ
J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805
[TBL] [Abstract][Full Text] [Related]
5. Positive Correlation Between 18 F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas.
Libé R; Pais A; Violon F; Guignat L; Bonnet F; Huillard O; Assié G; Gaillard M; Dousset B; Gaujoux S; Barat M; Dohan A; Sibony M; Bertherat J; Cottereau AS; Tenenbaum F; Coste J; Groussin L
Clin Nucl Med; 2023 May; 48(5):381-386. PubMed ID: 36758555
[TBL] [Abstract][Full Text] [Related]
6. Automated radiosynthesis of [
Hird M; Russell JJ; Corrigan LL; Boros I; Nordeman P; Antoni G; Gurnell M; Aigbirhio FI
J Labelled Comp Radiopharm; 2024 Feb; 67(2):67-75. PubMed ID: 38116667
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
Zettinig G; Mitterhauser M; Wadsak W; Becherer A; Pirich C; Vierhapper H; Niederle B; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1224-30. PubMed ID: 15197504
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Development of [
Bongarzone S; Basagni F; Sementa T; Singh N; Gakpetor C; Faugeras V; Bordoloi J; Gee AD
Nucl Med Biol; 2019; 68-69():14-21. PubMed ID: 30578137
[TBL] [Abstract][Full Text] [Related]
10. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
[TBL] [Abstract][Full Text] [Related]
11. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
[TBL] [Abstract][Full Text] [Related]
12. Superiority of 18 F-FDG PET/CT to 68 GA-FAPI PET/CT in Adrenocortical Tumor Imaging.
Kaplan İ; Can C; Kepenek F; Ibiloğlu İ; Güzel Y
Clin Nucl Med; 2023 Jun; 48(6):e307-e309. PubMed ID: 36754357
[TBL] [Abstract][Full Text] [Related]
13. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
Bergström M; Juhlin C; Bonasera TA; Sundin A; Rastad J; Akerström G; Långström B
J Nucl Med; 2000 Feb; 41(2):275-82. PubMed ID: 10688111
[TBL] [Abstract][Full Text] [Related]
15. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.
Wong KK; Miller BS; Viglianti BL; Dwamena BA; Gauger PG; Cook GJ; Colletti PM; Rubello D; Gross MD
Clin Nucl Med; 2016 Aug; 41(8):e368-82. PubMed ID: 26825212
[TBL] [Abstract][Full Text] [Related]
16. 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism.
Hennings J; Sundin A; Hägg A; Hellman P
Langenbecks Arch Surg; 2010 Sep; 395(7):963-7. PubMed ID: 20644954
[TBL] [Abstract][Full Text] [Related]
17. [18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers.
Wadsak W; Mitterhauser M; Rendl G; Schuetz M; Mien LK; Ettlinger DE; Dudczak R; Kletter K; Karanikas G
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):669-72. PubMed ID: 16568205
[TBL] [Abstract][Full Text] [Related]
18. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
Dimitrakopoulou-Strauss A; Strauss L
Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
[TBL] [Abstract][Full Text] [Related]
19. 11C-metomidate PET imaging of adrenocortical cancer.
Khan TS; Sundin A; Juhlin C; Långström B; Bergström M; Eriksson B
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):403-10. PubMed ID: 12634969
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [
Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L
Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]